Use of genetic modifications in human gene CHK1 which codes for checkpoint kinase 1
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 7, 2015
Grant Date -
Jul 25, 2013
app pub date -
Nov 1, 2012
filing date -
Nov 17, 2006
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention relates to an in vitro method for predicting disease risks, progression of diseases, drug risks, success of treatment and for finding drug targets by looking for one or more genetic modifications in the promoter region of the CHK1 (CHEK1) gene on human chromosome 11q23, the genetic modifications being a substitution thymine for guanine in position −1143 in the promoter of CHK1, of thymine for cytosine in position −1400, a substitution of cytosine for thymine in position −1453 or an insertion of one cytosine in position −1454 and the genetic modifications being detected individually or in any combinations by way of known methods.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully